Appetite Control
Tirzepatide delivers appetite control for patients seeking results without compromise.
Dual-action GIP/GLP-1 — the gold standard.
Starting At
$299/mo

Overview
Tirzepatide is a dual GIP/GLP-1 receptor agonist taken once weekly. It reduces appetite, slows gastric emptying and improves insulin sensitivity — delivering category-leading weight-loss results.
Benefits
Tirzepatide delivers appetite control for patients seeking results without compromise.
Tirzepatide delivers reduced food noise for patients seeking results without compromise.
Tirzepatide delivers weekly dosing for patients seeking results without compromise.
Tirzepatide delivers weight loss support for patients seeking results without compromise.
Available Strengths
Tap any strength to begin your guided assessment. A licensed provider sets the final dose.
FAQ
Patients Also Explore
Curated by our care team — medications patients commonly explore alongside this one.
Ready To Get Started?